For weight management, NICE eligibility criteria include: Body Mass Index (BMI) 35 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, obstructive sleep apnoea, or cardiovascular disease), OR BMI 30 kg/m in certain circumstances, particularly for individuals with type 2 diabetes where weight loss would provide significant metabolic benefit Evidence of previous attempts at weight management through lifestyle interventions (dietary modification and increased physical activity) Commitment to ongoing lifestyle changes and regular monitoring For individuals of South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family background , lower BMI thresholds may apply (typically 2.5 kg/m lower) due to increased cardiometabolic risk at lower body weights
Clinical Evidence on Semaglutide and Acid Reflux The relationship between semaglutide use and the incidence or exacerbation of acid reflux symptoms has become an important area of investigation in clinical medicine
That makes it different from medicines that act mainly through the GLP-1 pathway
A.T.M., J.C.E., K.B., and J.C.L
Keeping a symptom diary during your first month helps you track when dry mouth occurs and how it responds to management strategies, giving PlexusDx clinical data to personalize your ongoing care
